I have another question on the timeline here. I think Ms. Michaud was talking about stage 1 and stage 2 trials. Is your network going to continue down the path through all those trials so that we will complete all that work in Canada and the patients in those trials can benefit here in Canada?
On March 31st, 2022. See this statement in context.